JOHN DAVID HANSEN Insider Trading
Get free email notifications about insider trading for JOHN DAVID HANSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN DAVID HANSEN. JOHN DAVID HANSEN is a V.P. of Corporate Development in AVANIR PHARMACEUTICALS, INC. ($AVNR) and a President and CEO in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
Address: 11388 SORRENTO VALLEY ROAD, SUTIE 200 SAN DIEGO 92121 CA
Companies in which JOHN DAVID HANSEN is an Insider
AVANIR PHARMACEUTICALS, INC.
Trading Symbol: AVNRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN DAVID HANSEN: V.P. of Corporate Development
Holdings: 15,000 shares
Latest Transaction: Jan 03 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MABVAX THERAPEUTICS HOLDINGS, INC.
Trading Symbol: MBVXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN DAVID HANSEN: President and CEO
Holdings: 536,730 shares
Current Value: $1,594,088
Latest Transaction: Feb 23 2018
$MBVX Market Capitalization: $18.01M
$MBVX Previous Close: $2.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN DAVID HANSEN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | A | 2.04 | 290,000 | 591,600 | 290,000 | |
Feb 23 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | A | 2.04 | 290,000 | 591,600 | 290,000 | |
Jan 18 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.92 | 59,263 | 54,522 | 536,730 | 596 K to 536.7 K (-9.94 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Option Exercise | M | 0.00 | 727,210 | 0 | 0 | |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.96 | 18,582 | 17,839 | 595,993 | 614.6 K to 596 K (-3.02 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.98 | 64,015 | 62,735 | 614,575 | 678.6 K to 614.6 K (-9.43 %) |
Jan 16 2018 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | PRESIDENT AND CEO | Sell | S | 0.96 | 110,093 | 105,689 | 678,590 | 788.7 K to 678.6 K (-13.96 %) |